Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group.,Leukemia

当前位置： X-MOL 学术 › Leukemia › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Brentuximab vedotin-containing escalated BEACOPP variants for newly diagnosed advanced-stage classical Hodgkin lymphoma: follow-up analysis of a randomized phase II study from the German Hodgkin Study Group.
Leukemia ( IF 12.8 ) Pub Date : 2021-08-18 , DOI: 10.1038/s41375-021-01386-z
Carla Damaschin _{1,

2} , Helen Goergen _{1,

2} , Stefanie Kreissl _{1,

2} , Annette Plütschow _{1,

2} , Frank Breywisch ₃ , Stephan Mathas ₄ , Julia Meissner ₅ , Martin Sökler ₆ , Max S Topp ₇ , Vladan Vucinic ₈ , Andreas Zimmermann ₉ , Bastian von Tresckow _{2,

10} , Michael Fuchs _{1,

2} , Andreas Engert _{1,

2} , Peter Borchmann _{1,

2} , Dennis A Eichenauer _{1,

2}

Affiliation

First Department of Internal Medicine, University of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Dusseldorf, Cologne, Germany.
German Hodgkin Study Group (GHSG), University Hospital Cologne, Cologne, Germany.
Department of Hematology, Oncology and Palliative Care, Klinikum Ernst von Bergmann, Potsdam, Germany.
Department of Hematology, Oncology and Tumor Immunology, Charité-Universitätsmedizin Berlin, Max-Delbrück-Center for Molecular Medicine, Berlin, and Experimental and Clinical Research Center (ECRC), Berlin, Germany.
Fifth Department of Internal Medicine, University Hospital Heidelberg, Heidelberg, Germany.
Second Department of Internal Medicine, University Hospital Tübingen, Tübingen, Germany.
Second Department of Internal Medicine, University Hospital Würzburg, Würzburg, Germany.
Department of Hematology and Cell Therapy, Medical Oncology, Hemostaseology, University Hospital Leipzig, Leipzig, Germany.
Department of Internal Medicine III, University Hospital Munich, Munich, Germany.
Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.